Paul Weil

Paul Weil is the VP of Marketing Access at Avadel. Paul has over 25 years of experience in the pharmaceutical industry, working in a variety of marketing and sales roles.

Paul began their career as a Regional Account Manager at Eli Lilly and Company in 1988. Paul then moved to Schering-Plough in 1997, where they worked as an Employer Account Executive. In 2003, they joined Amylin Pharmaceuticals as a National Account Director.

Weil spent seven years at Amylin, before moving to Avanir Pharmaceuticals in 2010. Paul spent seven years at Avanir, before joining Greenwich Biosciences in 2017. Paul has been with Greenwich for four years.

Paul Weil received their BS in Business from the University of Delaware.

Paul Weil reports to Gregory J. Divis, CEO. They work with Jennifer Gudeman - VP, Medical & Clinical Affairs, Thomas S. McHugh - Chief Financial Officer, and Jason M. Vaughn - SVP, Technical Operations.